Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 58

1.

Structural basis for the broad substrate specificity of the human tyrosylprotein sulfotransferase-1.

Tanaka S, Nishiyori T, Kojo H, Otsubo R, Tsuruta M, Kurogi K, Liu MC, Suiko M, Sakakibara Y, Kakuta Y.

Sci Rep. 2017 Aug 18;7(1):8776. doi: 10.1038/s41598-017-07141-8.

2.

Prevalence of organic colonic lesions in patients meeting Rome III criteria for diagnosis of IBS: a prospective multi-center study utilizing colonoscopy.

Ishihara S, Yashima K, Kushiyama Y, Izumi A, Kawashima K, Fujishiro H, Kojo H, Komazawa Y, Hamamoto T, Yamamoto T, Sasaki Y, Shimizu T, Okamoto E, Yoshimura T, Furuta K, Noguchi N, Tanaka H, Murawaki Y, Kinoshita Y.

J Gastroenterol. 2012 Oct;47(10):1084-90. doi: 10.1007/s00535-012-0573-4. Epub 2012 Mar 30.

PMID:
22460220
3.

[Effectiveness of S-1 therapy for unresectable/advanced pancreas cancer].

Kanbe T, Kishimoto Y, Tsunoda H, Imamoto R, Mukouyama T, Nishimuki E, Shabana M, Kojo H.

Gan To Kagaku Ryoho. 2009 Sep;36(9):1475-80. Japanese.

PMID:
19755815
5.

Aberrant expression of selenoproteins in the progression of colorectal cancer.

Murawaki Y, Tsuchiya H, Kanbe T, Harada K, Yashima K, Nozaka K, Tanida O, Kohno M, Mukoyama T, Nishimuki E, Kojo H, Matsura T, Takahashi K, Osaki M, Ito H, Yodoi J, Murawaki Y, Shiota G.

Cancer Lett. 2008 Feb 8;259(2):218-30. Epub 2007 Dec 3.

PMID:
18054426
6.

Microarray profiling of gene expression in human adipocytes in response to anthocyanins.

Tsuda T, Ueno Y, Yoshikawa T, Kojo H, Osawa T.

Biochem Pharmacol. 2006 Apr 14;71(8):1184-97. Epub 2006 Feb 17.

PMID:
16483547
7.

A novel estrogen receptor-related protein gamma splice variant lacking a DNA binding domain exon modulates transcriptional activity of a moderate range of nuclear receptors.

Kojo H, Tajima K, Fukagawa M, Isogai T, Nishimura S.

J Steroid Biochem Mol Biol. 2006 Mar;98(4-5):181-92. Epub 2006 Feb 7.

PMID:
16460929
8.

Gene expression profile of isolated rat adipocytes treated with anthocyanins.

Tsuda T, Ueno Y, Kojo H, Yoshikawa T, Osawa T.

Biochim Biophys Acta. 2005 Apr 15;1733(2-3):137-47. Epub 2005 Jan 12.

PMID:
15863361
9.

Molecular cloning and characterization of two novel human RXR alpha splice variants.

Kojo H, Tajima K, Fukagawa M, Isogai T, Nishimura S.

J Steroid Biochem Mol Biol. 2004 Sep;92(1-2):19-28.

PMID:
15544927
10.

Pharmacological characteristics of a novel nonthiazolidinedione insulin sensitizer, FK614.

Minoura H, Takeshita S, Ita M, Hirosumi J, Mabuchi M, Kawamura I, Nakajima S, Nakayama O, Kayakiri H, Oku T, Ohkubo-Suzuki A, Fukagawa M, Kojo H, Hanioka K, Yamasaki N, Imoto T, Kobayashi Y, Mutoh S.

Eur J Pharmacol. 2004 Jun 28;494(2-3):273-81.

PMID:
15212984
11.

Evaluation of human peroxisome proliferator-activated receptor (PPAR) subtype selectivity of a variety of anti-inflammatory drugs based on a novel assay for PPAR delta(beta).

Kojo H, Fukagawa M, Tajima K, Suzuki A, Fujimura T, Aramori I, Hayashi K, Nishimura S.

J Pharmacol Sci. 2003 Nov;93(3):347-55.

12.

Adult-type neuroblastoma originated in retroperitoneum beginning with obstructive jaundice.

Kawakami M, Koda M, Matsunaga N, Kishimoto Y, Shabana M, Kato H, Nishimuki E, Kojo H, Miura K, Kawasaki H.

Clin Imaging. 2001 Jul-Aug;25(4):284-7.

PMID:
11566092
13.

Alteration in expression profiles of a series of diabetes-related genes in db/db mice following treatment with thiazolidinediones.

Suzuki A, Yasuno T, Kojo H, Hirosumi J, Mutoh S, Notsu Y.

Jpn J Pharmacol. 2000 Oct;84(2):113-23.

14.

Circulating p53 antibody in patients with colorectal cancer: relation to clinicopathologic features and survival.

Shiota G, Ishida M, Noguchi N, Oyama K, Takano Y, Okubo M, Katayama S, Tomie Y, Harada K, Hori K, Ashida K, Kishimoto Y, Hosoda A, Suou T, Kanbe T, Tanaka K, Nosaka K, Tanida O, Kojo H, Miura K, Ito H, Kaibara N, Kawasaki H.

Dig Dis Sci. 2000 Jan;45(1):122-8.

PMID:
10695624
15.

Nonpeptide mimic of bradykinin with long-acting properties.

Aramori I, Zenkoh J, Morikawa N, Asano M, Hatori C, Sawai H, Kayakiri H, Satoh S, Inoue T, Abe Y, Sawada Y, Mizutani T, Inamura N, Iwami M, Nakahara K, Kojo H, Oku T, Notsu Y.

Immunopharmacology. 1999 Dec;45(1-3):185-90.

PMID:
10615010
16.

Clinical evaluation of hepatocyte growth factor in patients with gastrointestinal and pancreatic diseases with special reference to inflammatory bowel disease.

Matsuno M, Shiota G, Umeki K, Kawasaki H, Kojo H, Miura K.

Res Commun Mol Pathol Pharmacol. 1997 Jul;97(1):25-37.

PMID:
9507565
17.

Nonpeptide mimic of bradykinin with long-acting properties at the bradykinin B2 receptor.

Aramori I, Zenkoh J, Morikawa N, Asano M, Hatori C, Sawai H, Kayakiri H, Satoh S, Inoue T, Abe Y, Sawada Y, Mizutani T, Inamura N, Nakahara K, Kojo H, Oku T, Notsu Y.

Mol Pharmacol. 1997 Jul;52(1):16-20.

PMID:
9224807
18.

FR146687, a novel steroid 5 alpha-reductase inhibitor: in vitro and in vivo effects on prostates.

Nakayama O, Hirosumi J, Chida N, Takahashi S, Sawada K, Kojo H, Notsu Y.

Prostate. 1997 Jun 1;31(4):241-9.

PMID:
9180934
19.

Induction of plasma hepatocyte growth factor in acute colitis of mice.

Matsuno M, Shiota G, Umeki K, Kawasaki H, Kojo H, Miura K.

Inflamm Res. 1997 May;46(5):166-7.

PMID:
9197986
20.

Novel subtype-selective nonpeptide bradykinin receptor antagonists FR167344 and FR173657.

Aramori I, Zenkoh J, Morikawa N, O'Donnell N, Asano M, Nakamura K, Iwami M, Kojo H, Notsu Y.

Mol Pharmacol. 1997 Feb;51(2):171-6.

PMID:
9203620
21.

Novel steroid 5 alpha-reductase inhibitor FK143: its dual inhibition against the two isozymes and its effect on transcription of the isozyme genes.

Kojo H, Nakayama O, Hirosumi J, Chida N, Notsu Y, Okuhara M.

Mol Pharmacol. 1995 Sep;48(3):401-6.

PMID:
7565619
22.

FK143, a novel nonsteroidal inhibitor of steroid 5 alpha-reductase: (2) In vivo effects on rat and dog prostates.

Hirosumi J, Nakayama O, Chida N, Inami M, Fagan T, Sawada K, Shigematsu S, Kojo H, Notsu Y, Okuhara M.

J Steroid Biochem Mol Biol. 1995 Apr;52(4):365-73.

PMID:
7734405
23.

FK143, a novel nonsteroidal inhibitor of steroid 5 alpha-reductase: (1) In vitro effects on human and animal prostatic enzymes.

Hirosumi J, Nakayama O, Fagan T, Sawada K, Chida N, Inami M, Takahashi S, Kojo H, Notsu Y, Okuhara M.

J Steroid Biochem Mol Biol. 1995 Apr;52(4):357-63.

PMID:
7734404
24.

[The histological changes in the spinal cord following percutaneous cervical cordotomy (PCC) and correlation of these changes with the efficacy of PCC].

Nagaro T, Tabo E, Kojo H, Amakawa K, Kimura S, Arai T, Sugita A.

Masui. 1995 Mar 3;44(3):325-30. Japanese.

PMID:
7745783
25.

[Case of familial adenomatous polyposis with myelodysplastic syndrome].

Tajima F, Endo A, Kawatani T, Umeki K, Yoshimura T, Kawasaki K, Kojo H, Norimoto M.

Nihon Naika Gakkai Zasshi. 1994 Dec 10;83(12):2161-2. Review. Japanese. No abstract available.

PMID:
7876710
26.

Subtype- and species-selectivity of a tachykinin receptor antagonist, FK888, for cloned rat and human tachykinin receptors.

Aramori I, Morikawa N, Zenkoh J, O'Donnell N, Iwami M, Kojo H, Notsu Y, Okuhara M, Ono S, Nakanishi S.

Eur J Pharmacol. 1994 Oct 14;269(2):277-81.

PMID:
7531648
27.

Subtype selectivity of a novel endothelin antagonist, FR139317, for the two endothelin receptors in transfected Chinese hamster ovary cells.

Aramori I, Nirei H, Shoubo M, Sogabe K, Nakamura K, Kojo H, Notsu Y, Ono T, Nakanishi S.

Mol Pharmacol. 1993 Feb;43(2):127-31.

PMID:
8429819
28.

An analysis of flow volume curves during artificial ventilation.

Ochi G, Kojo H, Yorozuya T, Kuzume K, Hamami G, Yamauchi Y, Nagaro T, Arai T.

J Anesth. 1993 Jan;7(1):120-3.

PMID:
15278508
29.
30.

Construction of a 7-aminocephalosporanic acid (7ACA) biosynthetic operon and direct production of 7ACA in Acremonium chrysogenum.

Isogai T, Fukagawa M, Aramori I, Iwami M, Kojo H, Ono T, Ueda Y, Kohsaka M, Imanaka H.

Biotechnology (N Y). 1991 Feb;9(2):188-91.

PMID:
1369453
31.

Cloning and nucleotide sequences of the complementary and genomic DNAs for the alkaline protease from Acremonium chrysogenum.

Isogai T, Fukagawa M, Kojo H, Kohsaka M, Aoki H, Imanaka H.

Agric Biol Chem. 1991 Feb;55(2):471-7.

32.

[Schoenlein-Henoch purpura in adult with intestinal irregular ulcers].

Yamamoto T, Shabana M, Nosaka Y, Kojo H, Miura K, Fujii T, Kawasaki H.

Nihon Shokakibyo Gakkai Zasshi. 1990 Dec;87(12):2651-5. Japanese. No abstract available.

PMID:
2077163
33.

Structure and expression of cDNA for D-amino acid oxidase active against cephalosporin C from Fusarium solani.

Isogai T, Ono H, Ishitani Y, Kojo H, Ueda Y, Kohsaka M.

J Biochem. 1990 Dec;108(6):1063-9.

34.

[An investigation into actual condition of outpatients at the Pedodontic Clinic of Showa University Dental Hospital. (3) An investigation into actual condition of the handicapped children].

Kojo H, Suzuki M, Tunoo A, Kasahara M, Simada Y, Satou M, Yamasita N, Inoue M, Sasa R.

Showa Shigakkai Zasshi. 1990 Sep;10(3):246-54. Japanese. No abstract available.

PMID:
2151830
35.

Nature of monocyclic beta-lactam antibiotic Nocardicin A to beta-lactamases.

Kojo H, Mine Y, Nishida M, Goto S, Kuwahara S.

Microbiol Immunol. 1988;32(2):119-30.

36.

Role of the cephalosporinase gene in the resistance of the clinically isolated cephem-resistant Escherichia coli.

Aramori I, Kojo H, Nishida M, Goto S, Kuwahara S.

J Antibiot (Tokyo). 1988 Jan;41(1):113-22.

38.
39.

[The anti-bacterial effect of the povidone-iodine gel for continuous epidural block].

Nagaro T, Kojo H, Hamada K, Amakawa K, Kimura S, Arai T, Takechi M.

Masui. 1984 Nov;33(11):1254-9. Japanese. No abstract available.

PMID:
6520926
40.

Mechanism of action of the new orally active cephalosporin FK027.

Shigi Y, Matsumoto Y, Kaizu M, Fujishita Y, Kojo H.

J Antibiot (Tokyo). 1984 Jul;37(7):790-6.

41.

In vitro and in vivo antibacterial properties of FK 027, a new orally active cephem antibiotic.

Kamimura T, Kojo H, Matsumoto Y, Mine Y, Goto S, Kuwahara S.

Antimicrob Agents Chemother. 1984 Jan;25(1):98-104.

42.

Yeast 2-micrometer plasmid DNA replication in vitro: origin and direction.

Kojo H, Greenberg BD, Sugino A.

Proc Natl Acad Sci U S A. 1981 Dec;78(12):7261-5.

43.

Differences between ceftizoxime and its stereoisomer in antibacterial activity and affinity for penicillin-binding proteins.

Shigi Y, Kojo H, Wakasugi M, Nishida M.

Antimicrob Agents Chemother. 1981 Mar;19(3):393-6.

44.

Pneumatosis cystoides intestinalis: Report of 3 cases with special reference to its non-surgical treatment.

Tamura N, Kojo H, Miyoshi Y, Fukumoto S, Hirayama C.

Z Gastroenterol. 1980 Dec;18(12):617-24.

PMID:
7281852
45.
46.
47.

FR-31564, a new phosphonic acid antibiotic: bacterial resistance and membrane permeability.

Kojo H, Shigi Y, Nishida M.

J Antibiot (Tokyo). 1980 Jan;33(1):44-8.

48.

Antibiotic resistance of indole-positive Klebsiella pneumoniae.

Kojo H, Asano J, Murakawa T, Nishida M.

Chemotherapy. 1980;26(6):431-5.

PMID:
6996947
49.

Supplemental Content

Support Center